CVA Family Office’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
722
+18
+3% +$6.67K 0.03% 284
2026
Q1
$206K Buy
704
+86
+14% +$28.3K 0.02% 320
2025
Q4
$217K Buy
618
+106
+21% +$35.8K 0.02% 281
2025
Q3
$165K Sell
512
-109
-18% -$33.9K 0.02% 323
2025
Q2
$242K Buy
621
+59
+10% +$23.7K 0.03% 261
2025
Q1
$244K Buy
562
+122
+28% +$49K 0.04% 251
2024
Q4
$162K Sell
440
-146
-25% -$61.1K 0.03% 301
2024
Q3
$305K Sell
586
-16
-3% -$8.55K 0.05% 197
2024
Q2
$326K Buy
602
+24
+4% +$12.7K 0.06% 181
2024
Q1
$300K Buy
578
+1
+0.2% +$497 0.05% 192
2023
Q4
$272K Buy
577
+20
+4% +$9.25K 0.05% 195
2023
Q3
$243K Buy
557
+111
+25% +$50.3K 0.06% 192
2023
Q2
$198K Sell
446
-73
-14% -$33.7K 0.04% 225
2023
Q1
$239K Buy
519
+54
+12% +$25.7K 0.05% 195
2022
Q4
$239K Buy
465
+10
+2% +$5.08K 0.06% 180
2022
Q3
$207K Buy
455
+20
+5% +$9.57K 0.06% 170
2022
Q2
$210K Sell
435
-75
-15% -$37.1K 0.06% 166
2022
Q1
$251K Buy
510
+150
+42% +$68.6K 0.06% 155
2021
Q4
$167K Buy
360
+285
+380% +$120K 0.04% 180
2021
Q3
$20K Sell
75
-300
-80% -$114K 0.01% 257
2021
Q2
$143K Buy
375
+90
+32% +$34.4K 0.04% 187
2021
Q1
$102K Buy
285
+210
+280% +$67.5K 0.04% 176
2020
Q4
$24K Hold
75
0.01% 256
2020
Q3
$20K Hold
75
0.01% 257
2020
Q2
$20K Hold
75
0.02% 221
2020
Q1
$17K Buy
+75
New +$20.4K 0.02% 208

Other funds holding ELV

CVA Family Office's ELV Position: Q2 2026 in Review

CVA Family Office increased its Elevance Health (ELV) stake by 2.6% in Q2 2026, buying an estimated $6.67K and bringing the position to 722 shares worth $279K. The position accounts for 0.03% of the portfolio, ranked #284.

CVA Family Office first reported a position in ELV in Q1 2020 and has held it in 26 quarters since. The position peaked at $326K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • CVA Family Office held 722 shares of Elevance Health worth $279K as of Q2 2026.
  • CVA Family Office bought 18 Elevance Health shares in Q2 2026, an estimated $6.67K.
  • Elevance Health made up 0.03% of CVA Family Office's portfolio in Q2 2026, its #284 holding.
  • CVA Family Office first reported a position in Elevance Health in Q1 2020 and has held it in 26 quarters since.
  • CVA Family Office's Elevance Health position peaked at $326K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.